
← The IMID Forum16 jul · 24 min
Discussing axSpA: Long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA
Discussing axSpA: Long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA
Join Dr Sofia Ramiro and Professor Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered the long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA.